Amit K. Sachdev is EVP, Chief Regulatory Officer at Vertex Pharmaceuticals, where he has served over the past decade in numerous executive leadership roles spanning the business as an executive officer and member of the Executive Committee. During this time, the Company experienced seven-fold growth and successfully developed and commercialized four novel breakthrough medicines for patients with serious liver disease and for patients with a life-threatening lung disease called cystic fibrosis. Today, Vertex is one of the world’s leading global biotechnology companies with its headquarters in Boston, Massachusetts.
Amit also serves as an independent board member for Eiger Biopharmaceuticals in Palo, Alto, CA and serves on several non-profit and philanthropic boards, including MassBIO, a biotechnology innovation association, and Imagine and Answer, a charity group focused on supporting research into rare forms of low-grade pediatric brain cancer. He also serves as a member of the Board of Advisors for Stanford University’s Center for Longevity Studies.